Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Femasys (FEMY)
NASDAQ:FEMY
Holding FEMY?
Track your performance easily
FEMY Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.29 - $4.75
Previous Close$1.12
Volume113.36K
Average Volume (3M)171.88K
Market Cap
$26.01M
Enterprise Value$16.13M
Total Cash (Recent Filing)$13.53M
Total Debt (Recent Filing)$4.76M
Price to Earnings (P/E)―
Beta-0.57
Next Earnings
Nov 07, 2024EPS Estimate
-$0.2Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.84
Shares Outstanding22,232,799
10 Day Avg. Volume133,342
30 Day Avg. Volume171,877
Standard Deviation0.99
R-Squared0.02
Alpha0.11
Financial Highlights & Ratios
Price to Book (P/B)2.20
Price to Sales (P/S)25.51
Price to Cash Flow (P/CF)-1.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue15.26
Enterprise Value/Gross Profit23.32
Enterprise Value/Ebitda-1.51
Forecast
1Y Price Target
$8.33Price Target Upside611.97% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
Femasys News
Bulls Say, Bears Say
Bulls Say
Innovative TreatmentFemaSeed is a novel and unique form of artificial insemination that delivers sperm directly to the fallopian tube, which should increase pregnancy success rates over current standard-of-care intrauterine insemination.
Market ExpansionTwo distributors secured in Spain for a minimum commitment of $1.3M, leading to initial ex-U.S. revenue.
Regulatory ApprovalFemasys obtains CE mark approval for four of its products, paving the way for commercialization in the EU market.
Bears Say
Cash ReservesThe company ended the quarter with cash and equivalents of $13.5 mm compared to $21.7 mm at the end of FY23.
Revenue PerformanceFemasys reported 2Q24 results with revenue of $0.2M, below our $1.8M and consensus of $0.8M, and a net loss of ($4.7M).
Share DilutionThe lower price target reflects a higher projected future share count as modeled future capital raises are expected to be more dilutive due to the decline in share price over the last quarter.
---
Ownership Overview
7.99%
Insiders
2.24% Mutual Funds
4.65% Other Institutional Investors
85.11% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
FEMY FAQ
What was Femasys’s price range in the past 12 months?
Femasys lowest stock price was $0.29 and its highest was $4.75 in the past 12 months.
What is Femasys’s market cap?
Currently, no data Available
When is Femasys’s upcoming earnings report date?
Femasys’s upcoming earnings report date is Nov 07, 2024 which is in 48 days.
How were Femasys’s earnings last quarter?
Femasys released its earnings results on Aug 08, 2024. The company reported -$0.21 earnings per share for the quarter, missing the consensus estimate of -$0.162 by -$0.048.
Is Femasys overvalued?
According to Wall Street analysts Femasys’s price is currently Undervalued.
Does Femasys pay dividends?
Femasys does not currently pay dividends.
What is Femasys’s EPS estimate?
Femasys’s EPS estimate is -$0.2.
How many shares outstanding does Femasys have?
Femasys has 22,232,800 shares outstanding.
What happened to Femasys’s price movement after its last earnings report?
Femasys reported an EPS of -$0.21 in its last earnings report, missing expectations of -$0.162. Following the earnings report the stock price went down -18.095%.
Which hedge fund is a major shareholder of Femasys?
Currently, no hedge funds are holding shares in FEMY
---
Femasys Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$8.33 (611.97% Upside)
$8.33 (611.97% Upside)
Blogger Sentiment
Bullish
FEMY Sentiment 100%
Sector Average 71%
Sector Average 71%
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.7%
Last 30 Days ▼ 4.9%
Last 30 Days ▼ 4.9%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
244.61%
12-Months-Change
Fundamentals
Return on Equity
-138.37%
Trailing 12-Months
Asset Growth
41.66%
Trailing 12-Months
Company Description
Femasys
Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. Its mission is to provide women with minimally-invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics.
---
FEMY Stock 12 Month Forecast
Average Price Target
$8.33
▲(611.97% Upside)
Technical Analysis
Best Analysts Covering FEMY
1 Year
1 Year Success Rate
8/13 ratings generated profit
1 Year Average Return
+20.66%
reiterated a buy rating last month
Copying Keay Nakae's trades and holding each position for 1 Year would result in 61.54% of your transactions generating a profit, with an average return of +20.66% per trade.
---